About Matrix Therapeutics
Matrix Therapeutics is a company based in Singapore (Singapore) founded in 2022 by Padma Reddy. It operates as a B2B. Matrix Therapeutics offers products and services including High Content Imaging Platform and CRO Services. Matrix Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Singapore, Singapore
- Founders Padma Reddy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Matrix Therapeutics Private Limited.
- Date of Incorporation 28 Nov, 2005
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$4.29 M (USD)52.99as on Mar 31, 2023
-
Net Profit
$252.66 K (USD)54.23as on Mar 31, 2023
-
EBITDA
$96.66 K (USD)-62.17as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Matrix Therapeutics
Matrix Therapeutics offers a comprehensive portfolio of products and services, including High Content Imaging Platform and CRO Services.
Platform for identifying repurposed drugs for medical conditions.
Services supporting product development and commercialization for sponsors.
Funding Insights of Matrix Therapeutics
Detailed funding history for Matrix Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Matrix Therapeutics
Investment portfolio details for Matrix Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Matrix Therapeutics
Detailed financials for Matrix Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Matrix Therapeutics Comparisons
Peer comparison for Matrix Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Matrix Therapeutics
Matrix Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Matrix Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Matrix Therapeutics
Complete news archive for Matrix Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Matrix Therapeutics
Matrix Therapeutics was founded in 2022.
Matrix Therapeutics is headquartered in Singapore, Singapore.
Annual revenue of Matrix Therapeutics is $4.29M as on Mar 31, 2023.
Matrix Therapeutics is an early-stage biotechnology company based in Singapore, specializing in discovering and commercializing repurposed drugs for conditions lacking effective treatments. It employs a proprietary high content imaging platform to support drug development. The company provides services in product development, strategy, and commercialization for biotechnology sponsors, acting as a discovery engine through a hybrid business approach.
Matrix Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Matrix Therapeutics offers High Content Imaging Platform and CRO Services.